Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

NYSE:CX - New York Stock Exchange, Inc. - US1512908898 - ADR - Currency: USD

6.08  +0.19 (+3.23%)

After market: 6.08 0 (0%)

Fundamental Rating

4

Overall CX gets a fundamental rating of 4 out of 10. We evaluated CX against 12 industry peers in the Construction Materials industry. Both the profitability and financial health of CX have multiple concerns. CX scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CX was profitable.
In the past year CX had a positive cash flow from operations.
Of the past 5 years CX 4 years were profitable.
CX had a positive operating cash flow in each of the past 5 years.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B

1.2 Ratios

CX has a worse Return On Assets (2.51%) than 83.33% of its industry peers.
CX has a worse Return On Equity (5.82%) than 83.33% of its industry peers.
CX has a Return On Invested Capital of 7.79%. This is in the lower half of the industry: CX underperforms 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CX is significantly below the industry average of 19.95%.
The 3 year average ROIC (6.67%) for CX is below the current ROIC(7.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.51%
ROE 5.82%
ROIC 7.79%
ROA(3y)2.24%
ROA(5y)0.37%
ROE(3y)5.79%
ROE(5y)0.15%
ROIC(3y)6.67%
ROIC(5y)5.81%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

CX's Profit Margin of 3.40% is on the low side compared to the rest of the industry. CX is outperformed by 91.67% of its industry peers.
In the last couple of years the Profit Margin of CX has declined.
The Operating Margin of CX (10.43%) is worse than 91.67% of its industry peers.
CX's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 33.93%, CX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
CX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.43%
PM (TTM) 3.4%
GM 33.93%
OM growth 3Y6%
OM growth 5Y-0.54%
PM growth 3YN/A
PM growth 5Y-23.14%
GM growth 3Y1.57%
GM growth 5Y-0.52%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CX is destroying value.
Compared to 1 year ago, CX has about the same amount of shares outstanding.
CX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CX has an improved debt to assets ratio.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

CX has an Altman-Z score of 1.57. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
CX has a worse Altman-Z score (1.57) than 75.00% of its industry peers.
The Debt to FCF ratio of CX is 11.04, which is on the high side as it means it would take CX, 11.04 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CX (11.04) is comparable to the rest of the industry.
CX has a Debt/Equity ratio of 0.58. This is a neutral value indicating CX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, CX is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 11.04
Altman-Z 1.57
ROIC/WACC0.59
WACC13.11%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.3 Liquidity

CX has a Current Ratio of 0.98. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, CX is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
A Quick Ratio of 0.73 indicates that CX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.73, CX is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.73
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 847.37% over the past year.
Measured over the past years, CX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
The Revenue has grown by 21.46% in the past year. This is a very strong growth!
CX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.14% yearly.
EPS 1Y (TTM)847.37%
EPS 3YN/A
EPS 5Y-16.04%
EPS Q2Q%11.11%
Revenue 1Y (TTM)21.46%
Revenue growth 3Y10.71%
Revenue growth 5Y5.14%
Sales Q2Q%-10.52%

3.2 Future

Based on estimates for the next years, CX will show a very strong growth in Earnings Per Share. The EPS will grow by 63.02% on average per year.
Based on estimates for the next years, CX will show a small growth in Revenue. The Revenue will grow by 3.25% on average per year.
EPS Next Y261.04%
EPS Next 2Y99.28%
EPS Next 3Y63.02%
EPS Next 5YN/A
Revenue Next Year-12.02%
Revenue Next 2Y-6.18%
Revenue Next 3Y1.26%
Revenue Next 5Y3.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50B 100B 150B 200B 250B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 20 -20 -40 -60

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1.13, which indicates a rather cheap valuation of CX.
Based on the Price/Earnings ratio, CX is valued cheaper than 91.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.51. CX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 2.68, which indicates a rather cheap valuation of CX.
Based on the Price/Forward Earnings ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 93.88.
Industry RankSector Rank
PE 1.13
Fwd PE 2.68
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CX is cheaper than 91.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.97
EV/EBITDA 4.42
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

CX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CX's earnings are expected to grow with 63.02% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y99.28%
EPS Next 3Y63.02%

5

5. Dividend

5.1 Amount

CX has a Yearly Dividend Yield of 18.67%, which is a nice return.
CX's Dividend Yield is rather good when compared to the industry average which is at 3.42. CX pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, CX pays a better dividend.
Industry RankSector Rank
Dividend Yield 18.67%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y99.28%
EPS Next 3Y63.02%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (1/30/2025, 5:05:00 PM)

After market: 6.08 0 (0%)

6.08

+0.19 (+3.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)10-28 2024-10-28/dmh
Earnings (Next)02-06 2025-02-06/amc
Inst Owners27.32%
Inst Owner Change-0.9%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.82B
Analysts81.18
Price Target5.97 (-1.81%)
Short Float %0.92%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield 18.67%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-10 2025-03-10 (0.008271)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.37%
Min EPS beat(2)-51.46%
Max EPS beat(2)-35.28%
EPS beat(4)1
Avg EPS beat(4)328.8%
Min EPS beat(4)-148.54%
Max EPS beat(4)1550.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.42%
Min Revenue beat(2)-8.32%
Max Revenue beat(2)-6.51%
Revenue beat(4)0
Avg Revenue beat(4)-5.36%
Min Revenue beat(4)-8.32%
Max Revenue beat(4)-2%
Revenue beat(8)1
Avg Revenue beat(8)-3.46%
Revenue beat(12)2
Avg Revenue beat(12)3.45%
Revenue beat(16)2
Avg Revenue beat(16)-15.52%
PT rev (1m)1.19%
PT rev (3m)-10.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.69%
Revenue NY rev (1m)-14.99%
Revenue NY rev (3m)-15.89%
Valuation
Industry RankSector Rank
PE 1.13
Fwd PE 2.68
P/S 0.43
P/FCF 12.97
P/OCF 4.45
P/B 0.73
P/tB 3.23
EV/EBITDA 4.42
EPS(TTM)5.4
EY88.82%
EPS(NY)2.27
Fwd EY37.27%
FCF(TTM)0.47
FCFY7.71%
OCF(TTM)1.37
OCFY22.46%
SpS14.27
BVpS8.34
TBVpS1.88
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.51%
ROE 5.82%
ROCE 9.86%
ROIC 7.79%
ROICexc 8.04%
ROICexgc 14.41%
OM 10.43%
PM (TTM) 3.4%
GM 33.93%
FCFM 3.29%
ROA(3y)2.24%
ROA(5y)0.37%
ROE(3y)5.79%
ROE(5y)0.15%
ROIC(3y)6.67%
ROIC(5y)5.81%
ROICexc(3y)6.93%
ROICexc(5y)6.05%
ROICexgc(3y)12.97%
ROICexgc(5y)11.52%
ROCE(3y)8.44%
ROCE(5y)7.36%
ROICexcg growth 3Y16.73%
ROICexcg growth 5Y6.31%
ROICexc growth 3Y18.38%
ROICexc growth 5Y7.78%
OM growth 3Y6%
OM growth 5Y-0.54%
PM growth 3YN/A
PM growth 5Y-23.14%
GM growth 3Y1.57%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 11.04
Debt/EBITDA 2.06
Cap/Depr 104.06%
Cap/Sales 6.28%
Interest Coverage 250
Cash Conversion 58.11%
Profit Quality 96.65%
Current Ratio 0.98
Quick Ratio 0.73
Altman-Z 1.57
F-Score8
WACC13.11%
ROIC/WACC0.59
Cap/Depr(3y)92.78%
Cap/Depr(5y)78.74%
Cap/Sales(3y)6.81%
Cap/Sales(5y)6%
Profit Quality(3y)234.17%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)847.37%
EPS 3YN/A
EPS 5Y-16.04%
EPS Q2Q%11.11%
EPS Next Y261.04%
EPS Next 2Y99.28%
EPS Next 3Y63.02%
EPS Next 5YN/A
Revenue 1Y (TTM)21.46%
Revenue growth 3Y10.71%
Revenue growth 5Y5.14%
Sales Q2Q%-10.52%
Revenue Next Year-12.02%
Revenue Next 2Y-6.18%
Revenue Next 3Y1.26%
Revenue Next 5Y3.25%
EBIT growth 1Y48.34%
EBIT growth 3Y17.35%
EBIT growth 5Y4.58%
EBIT Next Year62.69%
EBIT Next 3Y21.83%
EBIT Next 5Y13.46%
FCF growth 1Y-7.85%
FCF growth 3Y-1.32%
FCF growth 5Y0.39%
OCF growth 1Y2.33%
OCF growth 3Y10.21%
OCF growth 5Y6.62%